Haemonetics Return on Tangible Equity 2012-2025 | HAE
Current and historical return on tangible equity values for Haemonetics (HAE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Haemonetics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $0.17B | $-0.19B | -87.96% |
| 2025-06-30 | $0.16B | $-0.18B | -81.09% |
| 2025-03-31 | $0.17B | $-0.24B | -80.39% |
| 2024-12-31 | $0.13B | $-0.16B | -85.57% |
| 2024-09-30 | $0.12B | $-0.23B | -102.50% |
| 2024-06-30 | $0.11B | $-0.20B | -592.21% |
| 2024-03-31 | $0.12B | $-0.01B | 182.10% |
| 2023-12-31 | $0.13B | $-0.04B | 146.51% |
| 2023-09-30 | $0.13B | $0.18B | 124.88% |
| 2023-06-30 | $0.14B | $0.13B | 267.98% |
| 2023-03-31 | $0.12B | $0.08B | 621.62% |
| 2022-12-31 | $0.10B | $0.03B | -1280.00% |
| 2022-09-30 | $0.09B | $-0.03B | -296.55% |
| 2022-06-30 | $0.07B | $0.00B | -140.21% |
| 2022-03-31 | $0.04B | $-0.03B | -51.92% |
| 2021-12-31 | $0.02B | $-0.06B | -22.38% |
| 2021-09-30 | $0.03B | $-0.11B | 376.47% |
| 2021-06-30 | $0.07B | $-0.14B | 55.67% |
| 2021-03-31 | $0.08B | $-0.10B | 37.04% |
| 2020-12-31 | $0.11B | $0.38B | 36.12% |
| 2020-09-30 | $0.11B | $0.33B | 39.67% |
| 2020-06-30 | $0.10B | $0.25B | 37.94% |
| 2020-03-31 | $0.08B | $0.24B | 30.29% |
| 2019-12-31 | $0.08B | $0.26B | 29.01% |
| 2019-09-30 | $0.07B | $0.26B | 23.76% |
| 2019-06-30 | $0.05B | $0.26B | 16.19% |
| 2019-03-31 | $0.06B | $0.33B | 17.05% |
| 2018-12-31 | $0.05B | $0.30B | 13.68% |
| 2018-09-30 | $0.02B | $0.35B | 5.62% |
| 2018-06-30 | $0.02B | $0.31B | 5.62% |
| 2018-03-31 | $0.05B | $0.38B | 10.97% |
| 2017-12-31 | $-0.02B | $0.45B | -4.48% |
| 2017-09-30 | $0.00B | $0.42B | 1.08% |
| 2017-06-30 | $0.00B | $0.39B | 1.19% |
| 2017-03-31 | $-0.03B | $0.35B | -8.62% |
| 2016-12-31 | $0.02B | $0.32B | 5.80% |
| 2016-09-30 | $-0.06B | $0.29B | -22.66% |
| 2016-06-30 | $-0.07B | $0.25B | -27.60% |
| 2016-03-31 | $-0.06B | $0.25B | -24.20% |
| 2015-12-31 | $-0.05B | $0.24B | -21.61% |
| 2015-09-30 | $0.03B | $0.21B | 11.34% |
| 2015-06-30 | $0.02B | $0.22B | 8.53% |
| 2015-03-31 | $0.02B | $0.25B | 6.84% |
| 2014-12-31 | $0.03B | $0.25B | 12.64% |
| 2014-09-30 | $0.03B | $0.23B | 13.14% |
| 2014-06-30 | $0.04B | $0.21B | 18.71% |
| 2014-03-31 | $0.04B | $0.23B | 18.06% |
| 2013-12-31 | $0.04B | $0.21B | 21.14% |
| 2013-09-30 | $0.03B | $0.18B | 18.55% |
| 2013-06-30 | $0.02B | $0.15B | 13.25% |
| 2013-03-31 | $0.04B | $0.17B | 15.12% |
| 2012-12-31 | $0.05B | $0.18B | 12.81% |
| 2012-09-30 | $0.05B | $0.15B | 12.37% |
| 2012-06-30 | $0.06B | $0.55B | 11.85% |
| 2012-03-31 | $0.07B | $0.52B | 13.58% |
| 2011-12-31 | $0.07B | $0.49B | 14.57% |
| 2011-09-30 | $0.07B | $0.46B | 15.43% |
| 2011-06-30 | $0.08B | $0.50B | 17.65% |
| 2011-03-31 | $0.08B | $0.47B | 19.31% |
| 2010-12-31 | $0.06B | $0.44B | 16.04% |
| 2010-09-30 | $0.06B | $0.39B | 15.64% |
| 2010-06-30 | $0.06B | $0.36B | 14.45% |
| 2010-03-31 | $0.06B | $0.38B | 13.90% |
| 2009-12-31 | $0.07B | $0.43B | 15.96% |
| 2009-09-30 | $0.07B | $0.43B | 15.78% |
| 2009-06-30 | $0.06B | $0.43B | 15.57% |
| 2009-03-31 | $0.06B | $0.42B | 15.08% |
| 2008-12-31 | $0.06B | $0.40B | 15.50% |
| 2008-09-30 | $0.06B | $0.38B | 15.35% |
| 2008-06-30 | $0.05B | $0.37B | 14.30% |
| 2008-03-31 | $0.05B | $0.38B | 13.72% |
| 2007-12-31 | $0.06B | $0.36B | 14.96% |
| 2007-09-30 | $0.06B | $0.38B | 15.37% |
| 2007-06-30 | $0.05B | $0.41B | 12.67% |
| 2007-03-31 | $0.05B | $0.41B | 12.08% |
| 2006-12-31 | $0.05B | $0.39B | 11.42% |
| 2006-09-30 | $0.06B | $0.40B | 14.29% |
| 2006-06-30 | $0.07B | $0.42B | 17.39% |
| 2006-03-31 | $0.07B | $0.40B | 19.03% |
| 2005-12-31 | $0.06B | $0.38B | 18.21% |
| 2005-09-30 | $0.05B | $0.34B | 14.12% |
| 2005-06-30 | $0.04B | $0.33B | 14.39% |
| 2005-03-31 | $0.04B | $0.31B | 14.30% |
| 2004-12-31 | $0.04B | $0.29B | 15.30% |
| 2004-09-30 | $0.04B | $0.26B | 15.56% |
| 2004-06-30 | $0.03B | $0.25B | 14.93% |
| 2004-03-31 | $0.03B | $0.24B | 13.68% |
| 2003-12-31 | $0.02B | $0.22B | 11.63% |
| 2003-09-30 | $0.02B | $0.20B | 12.77% |
| 2003-06-30 | $0.03B | $0.19B | 14.27% |
| 2003-03-31 | $0.03B | $0.18B | 15.58% |
| 2002-12-31 | $0.03B | $0.18B | 17.39% |
| 2002-09-30 | $0.02B | $0.18B | 12.34% |
| 2002-06-30 | $0.03B | $0.18B | 13.19% |
| 2002-03-31 | $0.03B | $0.20B | 14.23% |
| 2001-12-31 | $0.03B | $0.23B | 14.03% |
| 2001-09-30 | $0.04B | $0.22B | 18.27% |
| 2001-06-30 | $0.01B | $0.20B | 5.90% |
| 2001-03-31 | $0.01B | $0.18B | 3.79% |
| 2000-12-31 | $0.00B | $0.19B | 0.53% |
| 2000-09-30 | $0.00B | $0.17B | -0.52% |
| 2000-06-30 | $0.02B | $0.20B | 10.10% |
| 2000-03-31 | $0.02B | $0.19B | 9.98% |
| 1999-12-31 | $0.03B | $0.20B | 12.20% |
| 1999-09-30 | $0.02B | $0.20B | 11.07% |
| 1999-06-30 | $0.02B | $0.21B | 10.62% |
| 1999-03-31 | $0.02B | $0.21B | 10.34% |
| 1998-12-31 | $-0.01B | $0.21B | -4.59% |
| 1998-09-30 | $-0.03B | $0.20B | -13.30% |
| 1998-06-30 | $-0.03B | $0.19B | -13.48% |
| 1998-03-31 | $-0.03B | $0.18B | -12.55% |
| 1997-12-31 | $0.01B | $0.21B | 2.79% |
| 1997-09-30 | $0.03B | $0.22B | 11.44% |
| 1997-06-30 | $0.03B | $0.22B | 13.68% |
| 1997-03-31 | $0.03B | $0.22B | 15.10% |
| 1996-12-31 | $0.03B | $0.22B | 15.74% |
| 1996-09-30 | $0.04B | $0.22B | 17.06% |
| 1996-06-30 | $0.04B | $0.21B | 17.69% |
| 1996-03-31 | $0.04B | $0.21B | 18.41% |
| 1995-12-31 | $0.04B | $0.20B | 19.07% |
| 1995-09-30 | $0.04B | $0.19B | 18.92% |
| 1995-06-30 | $0.04B | $0.18B | 19.26% |
| 1995-03-31 | $0.03B | $0.18B | 19.24% |
| 1994-12-31 | $0.03B | $0.19B | 19.38% |
| 1994-09-30 | $0.03B | $0.18B | 20.82% |
| 1994-06-30 | $0.03B | $0.16B | 21.77% |
| 1994-03-31 | $0.03B | $0.15B | 22.55% |
| 1993-12-31 | $0.03B | $0.14B | 23.21% |
| 1993-09-30 | $0.03B | $0.13B | 23.53% |
| 1993-06-30 | $0.03B | $0.12B | 23.03% |
| 1993-03-31 | $0.03B | $0.12B | 22.47% |
| 1992-12-31 | $0.02B | $0.12B | 23.41% |
| 1992-09-30 | $0.02B | $0.11B | 23.40% |
| 1992-06-30 | $0.02B | $0.10B | 23.39% |
| 1992-03-31 | $0.02B | $0.08B | 24.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.281B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |